Skip to contentC
Collegium Pharmaceutical, Inc
C
COLLCollegium Pharmaceutical, Inc Q1 2018 · 10-Q
Revenue$63.75M$63.75M+2,835.0% vs Q1 2017 Net Income-$18.65M-$18.65MN/M vs Q1 2017 EPS Diluted-$0.57-$0.57N/M vs Q1 2017 Operating Income-$13,207,000N/M Operating Cash Flow
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Collegium Pharmaceutical, Inc · CIK 1267565 · Engraved from SEC EDGAR
Free Cash Flowderived$29,307,000N/M Margins · derivedOperating margin-20.7%+1046.3 pt vs Q1 2017
Net margin-29.3%+1033.3 pt vs Q1 2017
ended Mar 31, 2018 · filed May 9, 2018 · 39 d after period end